Alterations in multiple biological functions, such as transcription factor activity, are implicated in the neurobiology of depression based primarily on the characterization of antidepressant efficacy in naïve rodents rather than on models that capture the protracted feelings of anhedonia and helplessness that typify depression. In order to address this issue, the authors developed protocols in rats and mice calling for chronic oral exposure to the stress-associated adrenal hormone, corticosterone (CORT), resulting in anhedonic-and helplessness-like behaviors that are persistent yet reversible by chronic antidepressant treatment. Prior CORT exposure also chronically influences molecular targets hypothesized to contribute to negative mood: One example is phosphorylation of cAMP Response Element Binding protein in the hippocampus and nucleus accumbens. Prior chronic CORT exposure provides an alternative method to chronic mild stress models of depression that is easily replicable and persists well beyond the CORT exposure period, thereby modeling the persistent depressive-like state in man.
Keywordsstress; corticosterone; anhedonia; helplessness; CREB; hippocampus; nucleus accumbens; antidepressant Depression is a debilitating and chronic illness characterized by feelings of helplessness, anhedonia, and loss of motivation to perform even everyday tasks. Although the relationship between stress and Major Depressive Disorder (MDD) is incompletely understood, stressinduced cortisol release from the adrenal glands and subsequent activation of glucocorticoid receptors in brain (c.f., de Kloet, 2004) likely plays a crucial role, as stressful life events are potent factors that trigger, induce, or exacerbate major depressive episodes. While no stressinduced depression-like syndrome in rodents can fully recapitulate the human condition, a model that produces a persistent, varied behavioral sequela (including helplessness, anhedonia, and loss of sensitivity to reward) sensitive to chronic antidepressant treatment would be a major advance for understanding the neurobiology of depression (c.f., Willner et al., 1987Willner et al., , 2005.Correspondence: Jane Taylor, PhD, CT Mental Health Center, Ribicoff Labs, 34 Park St., New Haven, CT 06508, jane.taylor@yale.edu;. NOTE: All protocols using live animals must first be reviewed and approved by an Institutional Animal Care and Use Committee (IACUC) or conform to governmental regulations regarding the care and use of laboratory animals.The authors declare they have no competing financial interests.
NIH Public Access
Author ManuscriptCurr Protoc Neurosci. Author manuscript; available in PMC 2010 October 1.
NIH-PA Author ManuscriptNIH-PA Author Manuscript
NIH-PA Author ManuscriptThis unit presents a depression model based on oral exposure to the stress hormone corticosterone (CORT) in its hemisuccinate form in rodents (also see Gourley et al., 2008; in press). The use of CORT hemisuccinate for oral administration provides an alternative to dissolving CORT in small amount...